Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Aron Hall and Fiona Havers.
Aron Hall
Connection Strength
1.125
Fiona Havers
  1. Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020. Clin Infect Dis. 2021 11 16; 73(10):1831-1839.
    View in: PubMed
    Score: 0.245
  2. Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey. Clin Infect Dis. 2021 11 02; 73(9):e3120-e3123.
    View in: PubMed
    Score: 0.244
  3. Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 11; 70(23):851-857.
    View in: PubMed
    Score: 0.238
  4. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21.
    View in: PubMed
    Score: 0.223
  5. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23; 70(29):1013-1019.
    View in: PubMed
    Score: 0.060
  6. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021 04 01; 181(4):450-460.
    View in: PubMed
    Score: 0.059
  7. Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 23; 69(42):1528-1534.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.